# Research Peptides in Israel: Legal Status, Suppliers & Import Guide 2026
Legal Framework for Research Peptides in Israel
Regulatory Overview
Israel's regulatory landscape for research peptides is governed by the Ministry of Health (MoH) and the Israeli Pharmaceutical Regulatory Authority. Unlike therapeutic pharmaceuticals, research-grade peptides occupy a distinct regulatory category:
Research-Use-Only (RUO) Status: Peptides explicitly labeled for research use are not classified as pharmaceutical drugs and are therefore not subject to the same pre-market approval requirements as therapeutic agents. This allows researchers to acquire peptides for investigational purposes without navigating full clinical trial pathways.
Non-Human Use Declaration: Israeli customs recognizes research peptides marked "Not for human consumption" as research chemicals, not drugs. This classification affects import duties and regulatory review.
Legal Exemptions for Research Institutions
Israeli academic institutions (universities, research hospitals, government research centers) benefit from:
- •Tax-exempt research procurement: Research materials may be imported with VAT exemptions (special import permits required)
- •Institutional import licenses: Authorized research institutions can establish streamlined import procedures
- •Safety exemptions: Institutional biosafety committees (ethical review equivalent for animal and cellular research) approve protocols but do not restrict peptide acquisition for approved research
- •No therapeutic claim restrictions: Research peptides can be studied for any application as long as they are not marketed for human consumption
Ministry of Health Approval
For peptides in clinical development or those under investigation by Israeli biotech companies, MoH approval is required for clinical trial IND applications, Investigational New Drug (IND) status, and manufacturing quality oversight. However, purely research-grade peptides used in academic and preclinical settings do not require MoH pre-approval.
Approved Suppliers Shipping to Israel
Domestic Israeli Suppliers
BioCom Israel (Jerusalem/Tel Aviv area)
- •Specializes in research-grade peptides and custom synthesis
- •Established supplier to Israeli biotech companies and academic institutions
- •Lead times: 2-4 weeks for standard compounds, 4-8 weeks for custom synthesis
- •Quality: GMP-grade, documented COAs (Certificates of Analysis)
Pharmalogical Research (Bnei Brak)
- •Peptide manufacturing and research compound distribution
- •ISO-certified manufacturing
- •Lead times: 3-6 weeks
- •Contact through institutional procurement channels
International Suppliers (Reliable Shipping to Israel)
Peptides International (Louisville, KY, USA)
- •Global leader in research peptide synthesis
- •Ships to Israeli research institutions (requires institutional documentation)
- •Lead times: 1-3 weeks
- •Quality: Full documentation, purity >95%
LifeTein (Hillsborough, NJ, USA)
- •US-based peptide synthesis company
- •Regular shipping to Israeli universities and hospitals
- •Custom peptide synthesis and catalog compounds
- •Lead times: 1-2 weeks
- •Quality: High purity, comprehensive analytical data
Bachem (Bubendorf, Switzerland)
- •European peptide manufacturer
- •Established supply chain to Israel
- •Full documentation, GMP-grade available
- •Lead times: 2-4 weeks
ProImmune (Oxford, UK)
- •Peptide synthesis and immunological reagents
- •Ships to Israeli research institutions
- •Quality: Clinical-grade, research-grade options
- •Lead times: 2-3 weeks
Import Procedures & Customs Regulations
Customs Classification
Research peptides are classified under Israeli Customs Code 2934.99 (Other nitrogenous heterocyclic compounds). This classification allows duty-free import status for research institutions, VAT exemption (with Special Import Permit), and expedited customs clearance (typical: 24-48 hours).
Required Documentation
For institutional import:
1. Import permit application (Rasham Chakirot—Israel Ministry of Economy)
- Institutional letterhead stating intended research use
- Researcher name, title, affiliation
- Compound name, quantity, supplier information
- Scientific justification (1-2 paragraphs)
- Processing time: 5-10 business days
2. Commercial invoice from supplier
- Itemized list: compound name, purity, quantity, unit price
- HS code: 2934.99.9000 (research chemical)
- "For Research Use Only—Not for Human Consumption" declaration
3. Supplier documentation
- Certificate of Analysis (CoA)
- Safety Data Sheet (SDS) when available
- Sequence/structural information for peptides
4. Institutional certification
- VAT exemption certificate (from Israeli institution)
- Biosafety committee approval (if using in cellular/animal research)
Customs Clearance Timeline
- •Shipment arrival: 1-2 business days (from customs broker notification)
- •Documentation review: 1-2 business days
- •Clearance: 1-2 business days
- •Total (typical): 3-5 business days from arrival
Israeli Biomedical Research Ecosystem
Leading Research Institutions
Weizmann Institute of Science (Rehovot)
- •Leading basic research institution
- •Active peptide research programs (aging, neuroscience, cancer)
- •World-class proteomics and structural biology capabilities
Tel Aviv University
- •Life sciences research programs
- •Department of Biomedical Engineering (peptide therapeutics)
- •Materials science and chemical engineering
Hebrew University of Jerusalem
- •Faculty of Medicine
- •Hadassah Medical Center affiliation
- •Neuroscience and aging research programs
Technion (Israel Institute of Technology)
- •Engineering and applied research focus
- •Biomedical engineering programs
- •Drug delivery and pharmaceutical chemistry research
Shaare Zedek Medical Center (Jerusalem)
- •Academic medical center
- •Clinical research infrastructure
- •Cardiovascular and metabolic research programs
Research Funding & Collaboration
- •Israel Science Foundation (ISF): Grants for basic peptide research
- •Chief Scientist Office: Supports pharmaceutical and biotech research
- •EU Horizon Europe: Funding for collaborations with European research centers
- •International collaborations: Israeli researchers frequently partner with US, EU institutions on peptide-focused projects
RUO Disclaimer
For research purposes only. Not for human consumption, therapeutic use, or medical treatment. All peptides referenced in this guide are investigational compounds not approved by the Israeli Ministry of Health or any regulatory agency for clinical use. Researchers must adhere to institutional biosafety protocols, ethical review approval, and applicable regulations.
---
References & Resources:
- •Israeli Ministry of Health: https://www.gov.il/en/departments/ministry_of_health
- •Israel Ministry of Economy: Import/Export regulations and customs procedures
- •Weizmann Institute of Science: https://www.weizmann.ac.il/
- •Tel Aviv University Faculty of Life Sciences: https://www.tau.ac.il/
- •Israel National Committee for Biotechnology: Government research infrastructure